Biodistribution and radiation dosimetry of the serotonin transporter ligand 11C-DASB determined from human whole-body PET

Journal of Nuclear Medicine

Volumn 45, Issue 9, 2004, Pages 1555-1559

  Lu, Jian Qiang ^a   Ichise, Masanori ^a   Liow, Jeih San ^a   Ghose, Subroto ^a   Vines, Doug ^a   Innis, Robert B ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

11C DASB; Dosimetry; PET; Serotonin transporter; Whole body biodistribution

Indexed keywords

3 AMINO 4 (2 DIMETHYLAMINOMETHYLPHENYLSULFANYL)BENZONITRILE C 11; RADIOLIGAND; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG; 3 AMINO 4 (2 DIMETHYLAMINOMETHYLPHENYLSULFANYL)BENZONITRILE; 3-AMINO-4-(2-DIMETHYLAMINOMETHYLPHENYLSULFANYL)BENZONITRILE; ANILINE DERIVATIVE; CARBON; CARRIER PROTEIN; DIAGNOSTIC AGENT; MEMBRANE PROTEIN; NERVE PROTEIN; RADIOPHARMACEUTICAL AGENT; SLC6A4 PROTEIN, HUMAN; SULFIDE;

ADULT; ARTICLE; BLADDER WALL; CONTROLLED STUDY; DOSIMETRY; DRUG ABSORPTION; DRUG DISTRIBUTION; FEMALE; GALLBLADDER; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; MALE; MICTURITION; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE; URINARY EXCRETION; ANTIBODY SPECIFICITY; BODY BURDEN; BRAIN; COMPUTER ASSISTED EMISSION TOMOGRAPHY; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; RADIOMETRY; RISK ASSESSMENT; SCINTISCANNING; TISSUE DISTRIBUTION; WHOLE BODY COUNTING;

ANILINE COMPOUNDS; BODY BURDEN; BRAIN; CARBON RADIOISOTOPES; CARRIER PROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METABOLIC CLEARANCE RATE; NERVE TISSUE PROTEINS; ORGAN SPECIFICITY; RADIATION DOSAGE; RADIOMETRY; RADIOPHARMACEUTICALS; RISK ASSESSMENT; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SULFIDES; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED; WHOLE-BODY COUNTING;

EID: 6944235696     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lucki I. The spectrum of behaviors influenced by serotonin. Biol Psychiatry. 1998;44:151-162.
2. Chen CP, Alder JT, Bowen DM, et al. Presynaptic serotonergic markers in community-acquired cases of Alzheimer's disease: correlations with depression and neuroleptic medication. J Neurochem. 1996;66:1592-1598.
3. Abi-Dargham A, Laruelle M, Aghajanian GK, Charney D, Krystal J. The role of serotonin in the pathophysiology and treatment of schizophrenia. J Neuropsychiatry Clin Neurosci. 1997;9:1-17.
4. Deakin JF. The role of serotonin in panic, anxiety and depression. Int Clin Psychopharmacol. 1998;13(suppl 4):S1-S5.
5. Charney DS. Monamine dysfunction and the pathophysiology and treatment of depression. J Clin Psychiatry. 1998;59:11-14.
6. Kugaya A, Seneca NM, Snyder PJ, et al. Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration. Neuropsychopharmacology. 2003;28:413-420.
7. Iversen L. Neurotransmitter transporters: fruitful targets for CNS drug discovery. Mol Psychiatry. 2000;5:357-362.
8. Ramamoorthy S, Blakely RD. Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science. 1999;285:763-766.
9. 11C]AFM. J Cereb Blood Flow Metab. 2002;22:1377-1298.
10. 11C-labeled 2-(phenylthio)araalkylamines. J Med Chem. 2000;43:3103-3110.
11. 11C]DASB. Eur J Nucl Med. 2000;27:1719-1722.
12. 11C]DASB binding to the human serotonin transporter: modeling strategies. J Cereb Blood Flow Metab. 2001;21:1342-1253.
13. 11C]DASB PET studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab. 2003;23:1096-1112.
14. 11C]-DASB: a probe for in vivo measurements of the serotonin transporter by positron emission tomography. Nucl Med Biol. 2002;29:509-515.
15. 11C]DASB determined from whole-body imaging in nonhuman primates. Nucl Med Commun. 2004;25:81-86.
16. Wrobel MC, Carey JE, Sherman PS, Kilbourn MR. Simplifying the dosimetry of carbon-11-labeled radiopharmaceuticals. J Nucl Med. 1997;38:654-660.
17. Cloutier RJ, Smith SA, Watson EE, Snyder WS, Warner GG. Dose to the fetus from radionuclides in the bladder. Health Phys. 1973;25:147-161.
18. Loevinger R, Budinger TF, Watson EE. MIRD Primer for Absorbed Dose Calculations. New York. NY: Society of Nuclear Medicine; 1991.
19. Radiological protection and safety in medicine. Ann ICRP. 1996;26. ICRP publication 73.
20. 11C]cyanoimipramine. Eur J Nucl Med. 2002;29:1289-1297.
21. Seibyl JP, Wallace E, Smith EO, et al. Whole-body biodistribution, radiation absorbed dose and brain SPECT imaging with iodine-123-CIT in healthy human subjects. J Nucl Med. 1994;35:764-770.
22. 11C] dapoxetine.HCI, a serotonin re-uptake inhibitor: biodistribution in rat and preliminary PET imaging in the monkey. Nucl Med Biol. 1994;21:669-675.
23. Hart CM, Block ER. Lung serotonin metabolism. Clin Chest Med. 1989;10:59-70.
24. Ramamoorthy S, Bauman AL, Moore KR, et al. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA. 1993;90:2542-2546.
25. Paczkowski NJ, Vuocolo HE, Bryan-Lluka LJ. Conclusive evidence for distinct transporters for 5-hydroxytryptamine and noradrenaline in pulmonary endothelial cells of the rat. Naunyn Schmiedebergs Arch Pharmacol. 1996;353:423-430.